[HTML] springer.comFull View

[HTML][HTML] Adalimumab biosimilars in the treatment of rheumatoid arthritis: a systematic review of the evidence for biosimilarity

TWJ Huizinga, Y Torii, R Muniz - Rheumatology and therapy, 2021 - Springer
Although treatment with biologic disease-modifying antirheumatic drugs (bDMARDs) has
significantly improved clinical outcomes in patients with rheumatoid arthritis (RA), many …
被引用次数：39 相关文章

[引用][C] Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity

TWJ Huizinga, Y Torii, R Muniz - Rheumatology and Therapy, 2020 - cir.nii.ac.jp
Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of
the Evidence for Biosimilarity | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity

TWJ Huizinga, Y Torii, R Muniz - Rheumatology and …, 2021 - pubmed.ncbi.nlm.nih.gov
Although treatment with biologic disease-modifying antirheumatic drugs (bDMARDs) has
significantly improved clinical outcomes in patients with rheumatoid arthritis (RA), many …

Adalimumab biosimilars in the treatment of rheumatoid arthritis: a systematic review of the evidence for biosimilarity

TWJ Huizinga, Y Torii, R Muniz - Rheumatology …, 2020 - scholarlypublications …
Although treatment with biologic disease-modifying antirheumatic drugs (bDMARDs) has
significantly improved clinical outcomes in patients with rheumatoid arthritis (RA), many …

Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity.

TWJ Huizinga, Y Torii, R Muniz - Rheumatology & Therapy, 2021 - search.ebscohost.com
Although treatment with biologic disease-modifying antirheumatic drugs (bDMARDs) has
significantly improved clinical outcomes in patients with rheumatoid arthritis (RA), many …
[HTML] nih.gov

[HTML][HTML] Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity

TWJ Huizinga, Y Torii, R Muniz - Rheumatology and Therapy, 2021 - ncbi.nlm.nih.gov
Although treatment with biologic disease-modifying antirheumatic drugs (bDMARDs) has
significantly improved clinical outcomes in patients with rheumatoid arthritis (RA), many …

Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity.

TWJ Huizinga, Y Torii, R Muniz - Rheumatology and Therapy, 2021 - go.gale.com
Although treatment with biologic disease-modifying antirheumatic drugs (bDMARDs) has
significantly improved clinical outcomes in patients with rheumatoid arthritis (RA), many …
[PDF] archive.org

[PDF][PDF] Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity

TWJ Huizinga, YTR Muniz - 2020 - scholar.archive.org
Although treatment with biologic diseasemodifying antirheumatic drugs (bDMARDs) has
significantly improved clinical outcomes in patients with rheumatoid arthritis (RA), many …

Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity

TWJ Huizinga, Y Torii, R Muniz - Rheumatology and Therapy, 2021 - search.proquest.com
Although treatment with biologic disease-modifying antirheumatic drugs (bDMARDs) has
significantly improved clinical outcomes in patients with rheumatoid arthritis (RA), many …

Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity.

TWJ Huizinga, Y Torii, R Muniz - Rheumatology and Therapy, 2020 - europepmc.org
Although treatment with biologic disease-modifying antirheumatic drugs (bDMARDs) has
significantly improved clinical outcomes in patients with rheumatoid arthritis (RA), many …